Aptamers are a small segment of oligonucleotides screened in vitro and can be highly affinity and strong with the corresponding ligands.
Scope of the Report:
This report focuses on the Aptamer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The combination of the opposite sex, its appearance provides a new research platform for high efficiency and fast recognition for the chemical and biomedical circles, and has shown good prospects in many aspects.
Nucleic acid aptamers are highly specific and highly selective in combination with a variety of target substances and are therefore widely used in the field of biosensors. When a nucleic acid aptamer specifically binds to a target substance, the configuration of the nucleic acid aptamer itself changes. Researchers have applied nucleic acid aptamers to probes and developed many electrochemical sensors based on the configuration changes of nucleic acid aptamers, also known as E-AB (Electrochemical aptamer-based) sensors, combined with electrochemical detection methods. The E-AB sensor improves the application of nucleic acid aptamers in the sensor field because of its portability, simple operation and low cost.
The worldwide market for Aptamer is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 440 million US$ in 2023, from 260 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
NewVentures Biotechnology
Aptamer Science
Aptagen
Aptamer Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nucleic acid Aptamer
Peptide Aptamer
Market Segment by Applications, can be divided into
Research, Diagnostics
Therapeutics
There are 15 Chapters to deeply display the global Aptamer market.
Chapter 1, to describe Aptamer Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Aptamer, with sales, revenue, and price of Aptamer, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Aptamer, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Aptamer market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Aptamer sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Aptamer Introduction
1.2 Market Analysis by Type
1.2.1 Nucleic acid Aptamer
1.2.2 Peptide Aptamer
1.3 Market Analysis by Applications
1.3.1 Research, Diagnostics
1.3.2 Therapeutics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 NewVentures Biotechnology
2.1.1 Business Overview
2.1.2 Aptamer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 NewVentures Biotechnology Aptamer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Aptamer Science
2.2.1 Business Overview
2.2.2 Aptamer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Aptamer Science Aptamer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Aptagen
2.3.1 Business Overview
2.3.2 Aptamer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aptagen Aptamer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aptamer Group
2.4.1 Business Overview
2.4.2 Aptamer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aptamer Group Aptamer Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Aptamer Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Aptamer Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Aptamer Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Aptamer Manufacturer Market Share in 2017
3.3.2 Top 6 Aptamer Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Aptamer Market Analysis by Regions
4.1 Global Aptamer Sales, Revenue and Market Share by Regions
4.1.1 Global Aptamer Sales and Market Share by Regions (2013-2018)
4.1.2 Global Aptamer Revenue and Market Share by Regions (2013-2018)
4.2 North America Aptamer Sales and Growth Rate (2013-2018)
4.3 Europe Aptamer Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Aptamer Sales and Growth Rate (2013-2018)
4.5 South America Aptamer Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Aptamer Sales and Growth Rate (2013-2018)
5 North America Aptamer by Countries
5.1 North America Aptamer Sales, Revenue and Market Share by Countries
5.1.1 North America Aptamer Sales and Market Share by Countries (2013-2018)
5.1.2 North America Aptamer Revenue and Market Share by Countries (2013-2018)
5.2 United States Aptamer Sales and Growth Rate (2013-2018)
5.3 Canada Aptamer Sales and Growth Rate (2013-2018)
5.4 Mexico Aptamer Sales and Growth Rate (2013-2018)
6 Europe Aptamer by Countries
6.1 Europe Aptamer Sales, Revenue and Market Share by Countries
6.1.1 Europe Aptamer Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Aptamer Revenue and Market Share by Countries (2013-2018)
6.2 Germany Aptamer Sales and Growth Rate (2013-2018)
6.3 UK Aptamer Sales and Growth Rate (2013-2018)
6.4 France Aptamer Sales and Growth Rate (2013-2018)
6.5 Russia Aptamer Sales and Growth Rate (2013-2018)
6.6 Italy Aptamer Sales and Growth Rate (2013-2018)
7 Asia-Pacific Aptamer by Countries
7.1 Asia-Pacific Aptamer Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Aptamer Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Aptamer Revenue and Market Share by Countries (2013-2018)
7.2 China Aptamer Sales and Growth Rate (2013-2018)
7.3 Japan Aptamer Sales and Growth Rate (2013-2018)
7.4 Korea Aptamer Sales and Growth Rate (2013-2018)
7.5 India Aptamer Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Aptamer Sales and Growth Rate (2013-2018)
8 South America Aptamer by Countries
8.1 South America Aptamer Sales, Revenue and Market Share by Countries
8.1.1 South America Aptamer Sales and Market Share by Countries (2013-2018)
8.1.2 South America Aptamer Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Aptamer Sales and Growth Rate (2013-2018)
8.3 Argentina Aptamer Sales and Growth Rate (2013-2018)
8.4 Colombia Aptamer Sales and Growth Rate (2013-2018)
9 Middle East and Africa Aptamer by Countries
9.1 Middle East and Africa Aptamer Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Aptamer Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Aptamer Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Aptamer Sales and Growth Rate (2013-2018)
9.3 UAE Aptamer Sales and Growth Rate (2013-2018)
9.4 Egypt Aptamer Sales and Growth Rate (2013-2018)
9.5 Nigeria Aptamer Sales and Growth Rate (2013-2018)
9.6 South Africa Aptamer Sales and Growth Rate (2013-2018)
10 Global Aptamer Market Segment by Type
10.1 Global Aptamer Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Aptamer Sales and Market Share by Type (2013-2018)
10.1.2 Global Aptamer Revenue and Market Share by Type (2013-2018)
10.2 Nucleic acid Aptamer Sales Growth and Price
10.2.1 Global Nucleic acid Aptamer Sales Growth (2013-2018)
10.2.2 Global Nucleic acid Aptamer Price (2013-2018)
10.3 Peptide Aptamer Sales Growth and Price
10.3.1 Global Peptide Aptamer Sales Growth (2013-2018)
10.3.2 Global Peptide Aptamer Price (2013-2018)
11 Global Aptamer Market Segment by Application
11.1 Global Aptamer Sales Market Share by Application (2013-2018)
11.2 Research, Diagnostics Sales Growth (2013-2018)
11.3 Therapeutics Sales Growth (2013-2018)
12 Aptamer Market Forecast (2018-2023)
12.1 Global Aptamer Sales, Revenue and Growth Rate (2018-2023)
12.2 Aptamer Market Forecast by Regions (2018-2023)
12.2.1 North America Aptamer Market Forecast (2018-2023)
12.2.2 Europe Aptamer Market Forecast (2018-2023)
12.2.3 Asia-Pacific Aptamer Market Forecast (2018-2023)
12.2.4 South America Aptamer Market Forecast (2018-2023)
12.2.5 Middle East and Africa Aptamer Market Forecast (2018-2023)
12.3 Aptamer Market Forecast by Type (2018-2023)
12.3.1 Global Aptamer Sales Forecast by Type (2018-2023)
12.3.2 Global Aptamer Market Share Forecast by Type (2018-2023)
12.4 Aptamer Market Forecast by Application (2018-2023)
12.4.1 Global Aptamer Sales Forecast by Application (2018-2023)
12.4.2 Global Aptamer Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Aptamer Picture
Table Product Specifications of Aptamer
Figure Global Sales Market Share of Aptamer by Types in 2017
Table Aptamer Types for Major Manuf